Who Owns IMNM?

Immunome, Inc. — Institutional Ownership & 13F Holdings

$23.32

+0.36 (+1.59%)

Market Cap

$2.1B

Shares Outstanding

87,860,759

Institutional Holders

142

Total Inst. Value

$23.4B

% of Float Held

105.6%

QoQ Holder Change

+52

Institutional data as of Q1 2025

New Positions

43

Closed Positions

18

Increased

69

Decreased

16

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1PRIMECAP MANAGEMENT CO/CA/$23.0B3,413,700
2T. Rowe Price Investment Management, Inc.$50.8M7,554,594
3BlackRock, Inc.$38.1M5,662,699
4Redmile Group, LLC$36.1M5,361,187
5Enavate Sciences GP, LLC$32.1M4,768,583
6Point72 Asset Management, L.P.$29.3M4,360,675
7VANGUARD GROUP INC$29.0M4,307,191
8EcoR1 Capital, LLC$27.5M4,079,415
9FMR LLC$26.2M3,892,318
10Opaleye Management Inc.$23.9M3,550,000

Biggest Buyers & Sellers This Quarter

Top Buyers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold IMNM?

As of Q1 2025, 142 institutional investors report holding IMNM (Immunome, Inc.) in their 13F filings.

What percentage of Immunome, Inc. is owned by institutions?

Institutional investors hold approximately 105.6% of Immunome, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most IMNM?

The largest institutional holder of IMNM is PRIMECAP MANAGEMENT CO/CA/ with $23.0B in shares.

Are institutions buying or selling IMNM?

This quarter, 43 institutions opened new positions in IMNM and 18 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.